0001578563-24-000325.txt : 20240625
0001578563-24-000325.hdr.sgml : 20240625
20240625165841
ACCESSION NUMBER: 0001578563-24-000325
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240621
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Adamio Anthony
CENTRAL INDEX KEY: 0001835184
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37844
FILM NUMBER: 241069716
MAIL ADDRESS:
STREET 1: C/O BIOVENTUS INC.
STREET 2: 4721 EMPEROR BOULEVARD, SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioventus Inc.
CENTRAL INDEX KEY: 0001665988
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 810980861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 474-6700
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
wk-form4_1719349115.xml
FORM 4
X0508
4
2024-06-21
0
0001665988
Bioventus Inc.
BVS
0001835184
D'Adamio Anthony
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM
NC
27703
0
1
0
0
SVP & General Counsel
1
Class A Common Stock
2024-06-21
4
S
0
5904
5.57
D
95576
D
Reflects shares sold to cover taxes upon the vesting of restricted stock units on June 20, 2024 pursuant to a standing 10b5-1 instruction adopted on June 20, 2023.
The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $5.515 to $5.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.
/s/ Anthony D'Adamio
2024-06-25